Status:
COMPLETED
Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis
Lead Sponsor:
Jinnah Sindh Medical University
Conditions:
Leishmaniasis, Cutaneous
Eligibility:
All Genders
4+ years
Phase:
NA
Brief Summary
Infections due to protozoa of the genus Leishmania are a major worldwide skin problem, with high endemicity in developing countries including Pakistan. As far as concern for the treatment of cutaneous...
Detailed Description
STUDY PROTOCOL 1.1. Introduction Leishmaniasis is a major neglected health problem frequently found in tropical and subtropical regions with the prevalence rate of 1.5 million per year globally. The ...
Eligibility Criteria
Inclusion
- The inclusion criteria for participants including;
- • Patients who met the histological criteria for presence of parasite
- Age of older than 4 years and both gender.
- Lesions are less than 5 in number in each patient
- Size of lesion is less than 5cm2
- Participants who had stopped therapy greater than 4 weeks earlier and the lesions were not improving.
- Duration of disease for patients under trial was six months (acute) and more than one year (chronic).
Exclusion
- The following patients were excluded:
- Whose clinical data were incomplete
- Participants who had received any anti anti-leishmanial or immunosuppressive drugs in the last 15 days
- Patients with co-morbid conditions, immunocompromised patients,
- Lactating mothers and pregnant women.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2014
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04841239
Start Date
January 1 2012
End Date
December 30 2014
Last Update
April 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Civil Hospital
Karachi, Sindh, Pakistan, 75850